# Sources — Theodore Roosevelt

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. U.S. National Park Service, Theodore Roosevelt Birthplace National Historic Site. “The Life of Theodore Roosevelt.” Supports his birth at 28 East 20th Street, New York City, on October 27, 1858; that “he was frequently ill with chronic asthma attacks” as a child, and that on bad nights his father took him out for carriage rides; his father's death in 1878 “shortly after being diagnosed with stomach cancer”; his Harvard degree in June 1880 and his 1881 election to the New York State Assembly; the 1914 Brazil expedition on which he “contracted jungle fever, injured his leg and lost sixty pounds”; and his death on January 6, 1919, “from a blood clot that had lodged in his heart.” https://www.nps.gov/thri/theodorerooseveltbio.htm
2. Roosevelt T. *Theodore Roosevelt: An Autobiography*. New York: Macmillan; 1913. Project Gutenberg eBook 3335. Chapter I supports “I was a sickly, delicate boy, suffered much from asthma, and frequently had to be taken away on trips to find a place where I could breathe,” the memory of sitting up in bed gasping at night, and his near-sightedness and first spectacles at about thirteen. Chapter II supports the asthma attack when he was nearly fourteen that sent him to Moosehead Lake and the boxing lessons and training that followed. https://www.gutenberg.org/ebooks/3335
3. Camargo CA Jr, Roosevelt T. “The Misunderstood Asthma of Theodore Roosevelt.” *J Allergy Clin Immunol Pract* 2015;3(5):696–701.e1. PMID 26271837. The abstract supports strong evidence for poorly controlled, persistent asthma beginning in early childhood, a relatively quiet stage in adolescence when his exercise program began at 12, continued serious exacerbations in adolescence and adulthood, and little if any support for the claim that the asthma was psychosomatic. Only the abstract was read. https://pubmed.ncbi.nlm.nih.gov/26271837/
4. Theodore Roosevelt Center at Dickinson State University. “Asthma” (TR Encyclopedia: The Strenuous Life). Corroborates that his symptoms eased as he grew but that he continued to suffer from asthma throughout his life. https://www.theodorerooseveltcenter.org/encyclopedia/strenuous-life/asthma/
5. U.S. National Park Service. “Life of Theodore Roosevelt.” Supports that he suffered from severe asthma as a child and that he died on January 6, 1919, at Sagamore Hill, Oyster Bay, New York. https://www.nps.gov/people/life-of-theodore-roosevelt.htm
6. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. Global Initiative for Asthma. *Global Strategy for Asthma Management and Prevention*, 2025 update. Track 1 maintenance-and-reliever therapy (MART) with budesonide-formoterol, no SABA-only treatment for adults, step-down after about three months of good control when exacerbation risk is low, management of exacerbations in primary care, and phenotyping with FeNO and blood eosinophils. The reports page now also lists a 2026 report, which was not reviewed. https://ginasthma.org/reports/
2. Cloutier MM, et al. “2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.” *J Allergy Clin Immunol* 2020;146(6):1217–1270. PMID 33280709. Severity classification by impairment, SMART at Steps 3 and 4, FeNO as an adjunct, multicomponent allergen mitigation only with documented sensitization, and subcutaneous immunotherapy in non-severe allergic asthma. https://pubmed.ncbi.nlm.nih.gov/33280709/
3. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), asthma monograph. Asthma Control Test, inhaler technique with the patient's own device, adherence, reliever use, exacerbation history, triggers and smoking, and action-plan review at every visit; review one to three months after starting or changing controller therapy, then every three to twelve months, and within one week of any exacerbation; spirometry at diagnosis, three to six months after stabilization, then every one to two years; home peak flow for moderate to severe asthma; FeNO, eosinophils, and IgE as indicated; comorbidity and vaccination review yearly; biologic candidacy only for severe uncontrolled asthma. https://patrickrutledge.github.io/topthirty/
4. Centers for Disease Control and Prevention. “Summary of Risk-based Pneumococcal Vaccination Recommendations.” For adults 19 to 49, chronic lung disease “includes chronic obstructive pulmonary disease, emphysema, and asthma.” https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/risk-indications.html
5. Medicare Preventive Services reference (Aether Forge, 2026). The preventive visit template (history fields, review of systems, examination, assessment and plan, and the screening cascade) that the preventive visit note follows. https://patrickrutledge.github.io/preventative_services/
6. U.S. Preventive Services Task Force. A and B recommendations; HIV Infection: Screening (2019); Hepatitis C Virus Infection in Adolescents and Adults: Screening (2020); Skin Cancer Prevention: Behavioral Counseling (2018). Used for the preventive visit. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations

## Editorial resolutions

- **Index age.** The episode presents him at 23, when he was a young man and a first-term legislator, the period in which the retrospective review describes continuing adult exacerbations of a lifelong asthma. The synthetic date of birth is October 27, 2002, so the whole-year shift is 144 years. The index visit is March 9, 2026 (true frame March 9, 1882); the chronic-care visits follow on April 6, June 8, and September 14, 2026 (true frame April 6, June 8, and September 14, 1882); the sick visit is August 3, 2026 (true frame August 3, 1882) and the preventive visit October 19, 2026 (true frame October 19, 1882), all before his 24th birthday and long before his death at 60.
- **Modern diagnosis.** His childhood asthma is documented in his own words (**D**). That it was persistent and continued into adulthood is a modern retrospective reading of the record (**R**, probable); the dates of individual adult exacerbations were not verified and are not recorded. The synthetic diagnosis is moderate persistent asthma with type 2 inflammation. His myopia is documented (**D**) and appears as a linked active problem.
- **Family history.** Only his father's death in 1878 is recorded, as the NPS states it. The deaths of his mother and his first wife on the same day in 1884 fall after the true-frame index date and are not used anywhere in the episode.
- **Not used.** The roster lists depression, grief, a boxing brain injury, and the loss of sight in one eye. Depression and brain injury were not verified in a fetched reliable source and are not recorded; no behavioral-health problem appears, so no safety assessment is required. The autobiography does describe the later loss of sight in one eye, but that injury came long after the index age and is not used. The remedies his doctors are said to have tried (black coffee, cigars, ipecac) appear only on a secondary page and are not used. Remarks attributed to his father about building his body are not used, because the brief forbids attributing statements to real relatives.
- **Cause of death.** The NPS wording, a blood clot that had lodged in his heart, is reported as written; it is not reinterpreted.
- **Spirometry category.** Spirometry, peak flow, and FeNO are measurements rather than laboratory specimens, so they use the `imaging` category, as eye pressure and other device measurements do in other records. The predicted values (FEV1 4.45 L, FVC 5.30 L, FEV1/FVC lower limit 0.72) are a synthetic reference set for a 23-year-old man 175 cm tall.
- **Sick and preventive visits.** The sick visit on August 3 is a moderate exacerbation triggered by a viral cold, chosen because viral infection is the commonest trigger and because it teaches exacerbation management in primary care on MART (a five-day prednisone course, no antibiotics or chest radiograph). It does not echo a dated historical episode. The preventive visit is `preventive_adult` because he is 23; it adds a synthetic outdated glasses prescription and sun-protection counseling, and its advance care planning names no real person as his health care agent.
- **Focused visits.** The three chronic-care follow-ups (four weeks, three months, and six months) are documented as focused visits on the CMID asthma monograph, with GINA 2025 and NAEPP 2020. Each lists every item the protocol calls for at that point, with its interval and status. The inhaler-technique errors at the four-week visit and the missed evening doses are synthetic. One deviation is recorded: the CMID calls for a clinic review within one week of any exacerbation, and the schedule has none after the August exacerbation (only a nurse telephone check at day three), so the six-month note records it as `deferred`, with no harm judged from later control and peak flow and a booking fix as corrective action. No result was invented for the missed review.
- **Consultation.** The pulmonology referral and consultation are synthetic. The consultant's phenotyping results (FeNO, eosinophils, total and dust mite IgE) are the results recorded at the four-week visit. Its recommendations match what followed: spirometry at three months, step-down only after control without exacerbation (deferred at six months after the August exacerbation), dust-mite covers, a pre-exercise reliever dose, PCV20 that day, and no immunotherapy or biologic.
- Roosevelt died in 1919, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
